DICHIARA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 964
EU - Europa 741
AS - Asia 237
AF - Africa 154
OC - Oceania 6
SA - Sud America 3
Totale 2.105
Nazione #
US - Stati Uniti d'America 943
IT - Italia 431
IE - Irlanda 132
CI - Costa d'Avorio 120
CN - Cina 112
SG - Singapore 105
RU - Federazione Russa 37
DE - Germania 36
SN - Senegal 33
CA - Canada 20
ES - Italia 18
UA - Ucraina 16
FR - Francia 13
GB - Regno Unito 11
CZ - Repubblica Ceca 9
JP - Giappone 9
NL - Olanda 7
SE - Svezia 7
VN - Vietnam 7
BE - Belgio 5
FI - Finlandia 5
AU - Australia 4
GR - Grecia 4
CH - Svizzera 3
HU - Ungheria 3
AT - Austria 2
BR - Brasile 2
IN - India 2
NZ - Nuova Zelanda 2
CL - Cile 1
EG - Egitto 1
IL - Israele 1
ME - Montenegro 1
MX - Messico 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 2.105
Città #
Chandler 295
Chicago 138
Dublin 131
Abidjan 120
Catania 114
Singapore 71
Ashburn 56
Boardman 54
Cambridge 33
Dakar 33
Lawrence 33
Andover 31
Nanjing 27
Bremen 21
Des Moines 21
Toronto 17
Jacksonville 16
Houston 12
Milan 12
Palermo 11
Centro 10
Madrid 10
Tokyo 9
Brno 8
Rome 8
Sala Baganza 8
Hebei 7
Messina 7
Naples 7
Shenyang 7
Wilmington 7
Moscow 6
Nanchang 6
Saint Petersburg 6
Scafati 6
Terrassa 6
Brussels 5
Changsha 5
Civitavecchia 5
Dong Ket 5
Groningen 5
Munich 5
Raffadali 5
Santa Clara 5
Bari 4
Jiaxing 4
Lappeenranta 4
Los Angeles 4
Marseille 4
Mascalucia 4
Pozzo Di Gotto 4
San Giovanni la Punta 4
Aci Catena 3
Beijing 3
Bologna 3
Budapest 3
Cagliari 3
Castelvetrano 3
Dearborn 3
Guangzhou 3
Kunming 3
Misterbianco 3
New Haven 3
New York 3
Ottawa 3
Porto San Giorgio 3
Randazzo 3
Redwood City 3
Reggio Calabria 3
Rimini 3
San Francisco 3
Tianjin 3
Villamagna 3
Washington 3
Zhengzhou 3
Chioggia 2
Como 2
Curitiba 2
Desio 2
Esslingen am Neckar 2
Florence 2
Foggia 2
Froges 2
Gatchina 2
Gela 2
Ghisalba 2
Grafing 2
Hangzhou 2
Hanoi 2
Kiev 2
Latina 2
Leawood 2
Marano Principato 2
Marquette 2
Marsala 2
Melbourne 2
Norwalk 2
Padova 2
Pune 2
Riposto 2
Totale 1.555
Nome #
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 101
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 86
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 82
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 80
Sigma-2 receptor ligands QSAR model dataset 76
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 71
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity 69
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 68
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 66
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 66
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 65
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 64
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 63
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 62
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 61
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 60
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 59
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics 58
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 57
CNS permeability parameters determination through a statistical analysis driven approach 55
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 54
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 53
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 51
Development of NO-releasing sigma receptor hybrids as anticancer agents 51
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 50
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 50
Composti inorganici [Cap. 6] 49
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 47
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 46
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 46
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 44
Repurposing of human kinase inhibitors in neglected protozoan diseases 41
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 37
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 35
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 31
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 29
H2S releasing molecules in pharmaceutical development 29
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties 29
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 27
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 19
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 17
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 17
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 13
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 13
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 12
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore 11
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 11
Totale 2.281
Categoria #
all - tutte 7.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 6 9 3 1 5 3 0 21 11 10
2020/2021145 5 1 14 34 44 2 15 1 5 0 10 14
2021/2022320 19 39 26 15 47 4 42 8 23 16 4 77
2022/2023745 69 66 15 107 49 116 8 123 143 9 34 6
2023/2024435 21 58 17 19 37 133 21 19 1 8 70 31
2024/2025323 55 214 54 0 0 0 0 0 0 0 0 0
Totale 2.281